Current Neuro-Oncology
Volume
27 Number 30
31 October 2025
Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 30, 31 October
Sylvester MA, Spinosa D, Encarnacion A, Berning A, Alldredge J.
Diagnosis and treatment of a mixed
ovarian malignant germ cell tumor with glioblastoma
transformation.
Gynecol
Oncol Rep. 2025 Sep 7;61:101945. doi:
10.1016/j.gore.2025.101945. PMID:
41169947. Case report. ˍ
Piotrowski AF, Shih K, Giglio P, Colman H, Wen PY, Campian JL,
Butowski N, Cloughesy T, Zhu Z, Gisin V, Badruddoja M.
Phase
Ib/II Study of Pamiparib Plus Radiation Therapy and/or
Temozolomide in Adult Patients with Treatment-Naïve or
Recurrent/Refractory Glioblastoma.
Curr
Oncol. 2025 Sep 27;32(10):541. doi:
10.3390/curroncol32100541. PMID:
41149461. Interventional study. ˍ
Wilson D, Jayappa S, Parker L, Ocal E, Tanaka T, Gokden M,
Bielamowicz K.
Targeted Inhibition in
Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective
Responses Followed by Treatment Resistance.
Int
J Mol Sci. 2025 Oct 10;26(20):9864. doi:
10.3390/ijms26209864. PMID:
41155159. Case report. ˍ
Saito R, Hanihara M, Okamoto T, Fujihara M, Muto Y, Kazama H,
Mochizuki K, Yoshioka H, Kinouchi H.
Antitumor
Effect of Selumetinib for Brainstem Glioma in an Adult With NF1: A
Case Report.
Neurosurg
Pract. 2025 Oct 13;6(4):e000175. doi:
10.1227/neuprac.0000000000000175. PMID:
41163739. Case report. ˍ
Levine AB, Bennett J, Patil P, Burns I, Siddaway R, Li C,
Haizel-Cobbina J, Rana M, Yuditskiy R, Son A, Nakano Y, Patel P,
Ho IC, Ku M, Lyons AT, Velázquez Vega JE, Schniederjan MJ,
Erker C, Cacciotti C, Santi M, Nelson EJ, Cheng S, Dunham C,
Wilson B, Black K, Van Landeghem F, Nobre L, Eisenstat DD,
Stücklin ASG, Weiser A, Larouche V, Giannakouros P, Fonseca
A, Williamson L, Fernandes IL, Plant-Fox AS, Fleming A, Campbell
S, Mushtaq N, Bukhari SI, Minhas K, Graham RT, Raskin S,
Jadrijevic-Cvrlje F, Ludlow L, Macneil MV, Mulcahy-Levy JM,
Demarsh S, Fukuoka K, Yamasaki K, Suzuki T, Ohka F, Kawamura A,
Arakawa Y, Ishihara T, Yamasaki F, Hansford JR, Luck A, Nasrallah
MP, Toledano H, Masoud RM, Lassaletta A, Blasco-Santana L, Kilday
JP, Talianski A, Davies C, Johnston J, Hale AT, Dirks PB, Rutka
JT, Dewan MC, Tabori U, Hawkins CE.
Integrated
clinical and molecular landscape of disseminated pediatric
low-grade glioma.
Neuro
Oncol. 2025 Oct 21:noaf245. doi:
10.1093/neuonc/noaf245. PMID:
41117845. Observational
study˰ ˍ
Wang MH, Zhang J, Yang L, Zhao J, Yao H, Xu H, Wu G, Hu J.
Development and validation of a
multi-parameter nomogram for venous thromboembolism in patients
undergoing surgery for brain tumors: a retrospective analysis.
Neurosurg
Rev. 2025 Oct 21;48(1):727. doi:
10.1007/s10143-025-03887-2. PMID:
41117840. Observational
study˰ ˍ
Cheng C, Zhao C, Liang B, Sun Y, Zhao D, Ma P, Wang C, Wang D, Pan
C, Zhai Y, Yu M, Zhang Z, Li G, Jiang T, Zhang W.
Strategy
and clinical benefit of first re-resection for recurrent
adult-type diffuse glioma: A retrospective cohort analysis.
Med.
2025 Oct 22:100891. doi:
10.1016/j.medj.2025.100891. PMID:
41130212. Observational
study˰ ˍ
*Xu L, Yu D, Li F, Ding X, Cao Y.
A
retrospective study of 30 cases evaluating the efficacy and safety
of anlotinib plus Temozolomide for recurrent/residual glioma from
a single center.
BMC
Cancer. 2025 Oct 22;25(1):1623. doi:
10.1186/s12885-025-15123-7. PMID:
41126110. Observational study. ˍ
Singh K, Foster MW, Violette MJ, Corcoran AM, Hotchkiss KM,
Railton CO, Blandford EE, Blethen KE, Thomas EL, McIntosh WC,
Ashley DM, Desjardins A, Friedman HS, Johnson MO, Friedman A, Keir
S, Buckley ED, Herndon JE, McLendon RE, Sampson JH, Calabrese E,
López GY, Grant GA, Patel AP, Gregory SG, Li CY, Fecci PE,
Khasraw M.
A surgical window of
opportunity trial evaluating the effect of the PCSK9 inhibitor
evolocumab on tumoral MHC-I expression and CD8+
infiltration in glioma.
Sci
Rep. 2025 Oct 23;15(1):37112. doi:
10.1038/s41598-025-21064-9. PMID:
41131134. Interventional study. ˍ
Bessette J, Arditi J, Noreck J, Edwards R, Kaiserman J, Wortelboer
R, Nguyen MA, Siwik W, Gautam S, Szymanski T, Wong ET.
Medical
comorbidities prognosticate survival in glioblastoma.
BJC
Rep. 2025 Oct 24;3(1):75. doi:
10.1038/s44276-025-00189-4. PMID:
41136649. Observational study. ˍ
Ghalibafian M, Mirzaei S, Sadeghi Y, Afsar N, Yeganeh SH, Tasbihi
M, Ashrafi M, Lahijani NJ, Bouffet E.
Diffuse
pontine glioma (DPG): shorter or longer treatment time?
J
Neurooncol. 2025 Oct 24;176(1):40. doi:
10.1007/s11060-025-05308-2. PMID:
41134453. Observational
study˰
ˍ
Hoosemans LJN, Panayotopoulos LF, van Kuijk SMJ, Verduin M, Anten
MHME, Pasmans RCOS, Schellekens JM, Huijs SMH, Verhoeff SR, van
den Berkmortel FWPJ, Steggink LC, Ackermans L, Schijns OEMG,
Teernstra OPM, Hovinga K, Beckervordersandforth JC, Compter I,
Eekers DBP, Postma AA, Vooijs MA, Broen MPG, Hoeben A.
Clinical
predictors of pseudoprogression in glioblastoma: a retrospective
cohort analysis.
J
Neurooncol. 2025 Oct 24;176(1):42. doi:
10.1007/s11060-025-05299-0. PMID:
41134378. Observational study. ˍ
Lin T, Ke S, Hu C, Assadi R, Huang J, Gupta S, Rawojc K, Kleinberg
L, Mukherjee D, Rincon-Torroella J, Weingart JD, Holdoff M,
Grossman S, Ahmed MM, Redmond KJ.
Low
Dose Fractionated Radiation Therapy As a Chemo-Potentiator of
Temozolomide for Recurrent Anaplastic Astrocytoma and
Glioblastoma: A Single-Arm Phase I/II Trial.
Int
J Radiat Oncol Biol Phys. 2025 Oct
24:S0360-3016(25)06396-5. doi:
10.1016/j.ijrobp.2025.10.014. PMID:
41138784. Interventional
study˰ ˍ
Smith AKS, Dhanda SK, Billups CA, Sioson E, Lu C, Peraza AZ,
Gangwani K, Li Y, Li Q, Lin T, Michalski JM, Packer RJ, Olson JM,
Leary SES, Fouladi M, Gajjar A, Zhou X, Onar-Thomas A, Northcott
PA, Robinson GW.
An integrated
analysis of three medulloblastoma clinical trials refines
risk-stratification approaches for reducing toxicity and improving
survival.
Neuro
Oncol. 2025 Oct 24:noaf250. doi:
10.1093/neuonc/noaf250. PMID:
41159377. Interventional study. ˍ
Tang LK, Sun Y, Zhang MH, Jiang H, Li ZK, Du GB.
Combined
temozolomide, immunotherapy and radiotherapy in a patient with
anaplastic oligodendroglioma and multiple extracranial metastases:
A rare case report.
Medicine
(Baltimore). 2025 Oct 24;104(43):e45142. doi:
10.1097/MD.0000000000045142. PMID:
41137316Case report. ˍ
Wang X, Zuo Z, Yu S, Lin S, Yu T.
Long-term
clinical prognosis of patients with gliomas infiltrating
corticospinal tract on DTI tractography.
Chin
Neurosurg J. 2025 Oct 24;11(1):26. doi:
10.1186/s41016-025-00412-8. PMID:
41137160. Observational study. ˍ
Nguyen MK, Jelinek M, Singh A, Isett B, Myers ES, Mullett SJ,
Eisele Y, Beumer JH, Parise RA, Urban J, Rose A, Sellitto L, Singh
K, Doerfler R, Dadey RE, Kim C, Rhee JC, Davar D, Villaruz LC,
Burgess M, Drappatz J, Mantica M, Goodman AE, Wang H, Singhi AD,
Luke JJ, Zandberg DP, Bao R.
Clinical
and translational study of ivosidenib plus nivolumab in advanced
solid tumors harboring IDH1 mutations.
Oncologist.
2025 Oct 25:oyaf362. doi:
10.1093/oncolo/oyaf362. PMID:
41138165. Interventional study. ˍ
Teske N, Dono A, Young JS, Juenger ST, Youssef GC, Häni L,
Sciortino T, Bruno F, Dietrich J, Mau CY, Weller M, Beck J,
Hervey-Jumper S, Molinaro AM, Chang SM, van den Bent M, Vogelbaum
MA, Ruge MI, Cahill DP, Rudà R, Bello L, Grau SJ, Schnell
O, Huang RY, Wen PY, Tandon N, Berger MS, Tonn JC, Esquenazi Y,
Karschnia P.
Associations of
supramaximal resection with outcome in glioblastoma across age
groups: a report of the RANO resect group.
Neuro
Oncol. 2025 Oct 25:noaf239. doi:
10.1093/neuonc/noaf239. PMID:
41137668. Observational
study˰
ˍ
Bartsch R, Marhold M, Garde-Noguera J, Gion M, Ruiz-Borrego M,
Greil R, Valero M, Llombart-Cussac A, García-Mosquera JJ,
Arumi M, Cortés J, Campolier M, Guerrero JA, Slebe F,
Martínez-García E, Jiménez-Cortegana C,
Vaz-Batista M, Oberndorfer F, Furtner J, Fuereder T, Berghoff AS,
Preusser M.
Patritumab deruxtecan
(HER3-DXd) in patients with active brain metastases of breast
cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial.
Lancet
Oncol. 2025 Oct 27;26(11):1467-1478. doi:
10.1016/S1470-2045(25)00470-X. PMID:
41167215. Interventional
study˰
Bergman L, Agur A, Gabay S, Tankus A, Strauss I, Zach L,
Aizenstein O, Grossman R, Shahar T, Strauss I.
Imaging
changes and Clinical outcome after MR-guided Laser Interstitial
Thermal Therapy.
Stereotact
Funct Neurosurg. 2025 Oct 27:1-23. doi:
10.1159/000549229. PMID:
41144626. Observational study. ˍ
Fuereder T, Garde-Noguera J, García-Mosquera JJ,
Ruiz-Borrego M, Valero M, Llombart-Cussac A, Gion M, Greil R,
Arumi M, Campolier M, Guerrero JA, Raimondi G, Mancino M,
Jiménez-Cortegana C, Vaz-Batista M, Oberndorfer F, Marhold
M, Berghoff AS, Furtner J, Bartsch R, Preusser M.
Patritumab
deruxtecan (HER3-DXd) in patients with active brain metastases of
non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm,
phase 2 trial.
Lancet
Oncol. 2025 Oct 27;26(11):1454-1466. doi:
10.1016/S1470-2045(25)00465-6. PMID:
41167214. Interventional
study˰ ˍ
Sun Y, Hamo M, Atchley T, Markert JM, Nabors B, Estevez-Ordonez D.
Survival outcomes associated with
antidepressant use in glioblastoma: a cohort study.
J
Neurooncol. 2025 Oct 27;176(1):47. doi:
10.1007/s11060-025-05288-3. PMID:
41144062. Observational study. ˍ
Yoshioka M, Noguchi S, Iwadate Y, Kobayashi M, Motohashi S,
Higuchi Y.
MGMT Promoter Methylation
in Glioblastoma Stem Cells: Stability During Differentiation and
Comparison With Surgically-resected Tumors.
Anticancer
Res. 2025 Oct 28;45(11):4959-4969. doi:
10.21873/anticanres.17839. PMID:
41151883. Laboratory investigation˰
ˍ
Del Baldo G, Di Ruscio V, Cacchione A, Lo Sasso A, Corvino L,
D'Orazio C, De Salvo A, Albino G, Cipri S, Miele E, Giovannoni I,
Rossi S, Colafati GS, Vennarini S, Carai A, Mastronuzzi A.
Clinical, toxicity and long-term
neurocognitive outcomes of first-line intensive chemotherapy in
infant medulloblastoma: a single-center cohort study following
AIEOP recommendations.
J
Neurooncol. 2025 Oct 29;176(1):54. doi:
10.1007/s11060-025-05301-9. PMID:
41160229. Observational study. ˍ
Wu Y, Ren Y, Li S, Zeng M, Wang J, Li M, Peng Y.
Association
between intraoperative hypotension during brain tumor resection
and postoperative delirium: A secondary analysis of a randomized
controlled trial.
PLoS
One. 2025 Oct 29;20(10):e0334094. doi:
10.1371/journal.pone.0334094. PMID:
41160633. Interventional study. ˍ
Bilski M, Noël G, Smółka K, Kuncewicz K, Kuźnicki
W, Feuvret L, Korab K, Peszyńska-Piorun M, Korona P,
Baranowska I, Suleja A, Le Fevre C, Schott R, Somme L, Chabli S,
Mesny E, Mastroleo F, Kotecha R, Jurkiewicz J, Fijuth J,
Jereczek-Fossa BA, Krystkiewicz K, Harat M, Kuncman Ł.
Real-world survival and prognostic
factors in WHO 2021 classified gliomas treated with
chemo-radiotherapy.
Sci
Rep. 2025 Oct 30;15(1):38011. doi:
10.1038/s41598-025-21934-2. PMID:
41168285. Observational
study. ˍ